(Q36007709)

English

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

inflammatory bowel diseases

0 references

0 references

Gert Van Assche

1

object named as

Gert Van Assche

0 references

2

object named as

Paul Rutgeerts

0 references

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

288

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

G169-74

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Beta2 integrin/ICAM expression in Crohn's disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Natalizumab for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Critical role for β7 integrins in formation of the gut-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00423.2004

21 January 2018

Identifiers

10.1152/AJPGI.00423.2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36007709&oldid=1867062144"